Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 24 - Minutes of Proceedings

OTTAWA, Wednesday, October 31, 2012
(57)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:21 p.m., in room 2, Victoria Building, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Cordy, Dyck, Eaton, Eggleton, P.C., Enverga, Martin, Munson, Ogilvie, Seidman, Seth and Verner, P.C. (11).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

United States Food and Drug Administration:

Dr. Gerald Dal Pan, Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (by video conference);

Dr. Robert Temple, Deputy Center Director for Clinical Science, Center for Drug Evaluation and Research (by video conference).

The chair made a statement.

Dr. Dal Pan made a statement and, together with Dr. Temple, answered questions.

At 5:28 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee